Reach Us +1-217-403-9671
Evaluation Of Anti-nociceptive Activity Of Aqueous Extract Of Root Of Ricinus Communis Linn On Albino Rats | 7479
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Evaluation of anti-nociceptive activity of aqueous extract of root of ricinus communis linn on albino rats

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Sayequa Samreen and T. Jayasree

Posters: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.007

Evaluation of Anti-nociceptive activity of aqueous extract of root of Ricinus communis linn on albino rats. The castor oil plant, Ricinus communis, is a species of flowering plant in the spurge family, Euphorbiaceae. It belongs to a monotypic genus, Ricinus, and subtribe, Ricininae. Water extract of root has showed some analgesic activity in rats. It also has anti-inflammatory and anti-histaminic properties. These properties are speculated to the presence of ricinoleic acid, dihydroxystearic, linoleic, oleic, stearic acids, beta-sitosterol, catalase, peroxidase, and reductase. Materials used are, Aqueous extract of root of Ricinus communis (AERRC), Soxhlet?s apparatus for extraction, Albino rats, Tail clip, Standard drug: Aspirin. Five groups of albino rats will be taken each consisting of five animals. Group-I will be taken as control to which normal saline will be given, Group-II standard drug will be given, Aspirin, Group III, IV, V test drug will be given AERRC(100mg/kg,200mg/kg,400mg/kg). Results will be discussed at the time of presentation.